— Know what they know.
Not Investment Advice

RXEI OTC

RxElite, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -75.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $1483 mcap · 12M float · 0.0016% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume200
Avg Volume184
Beta6.40
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORichard Tener
Employees47
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-02-18
1404 North Main
Meridian, ID 83642
US
208-288-5550
About RxElite, Inc.

RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liquid Dose offerings, such as generic ophthalmic solutions (available in both unit-dose and multi-dose formats), sterile unit-dose respiratory inhalation products, and various injectable medications. Beyond its finished drug products, the company, operating through its subsidiaries, also serves as a manufacturer of active pharmaceutical ingredients (APIs) for other pharmaceutical entities across the United States, Europe, and Asia. RxElite's extensive customer base includes institutional clients like hospitals and hospital group purchasing organizations, national and regional wholesale distributors, major direct retail pharmacy chains, home healthcare providers, and various outpatient surgery centers and ambulatory care clinics. The company maintains strategic alliances with industry partners such as Stason Pharmaceuticals, Inc., Alkem Laboratories Limited, and Zach Systems S.p.A. Headquartered in Meridian, Idaho, RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
RECTOR DAVID A-Award 100,000 — 2008-06-04
RECTOR DAVID A-Award 1,000,000 — 2008-06-04
AUERBACH MARK A-Award 100,000 — 2008-06-04
AUERBACH MARK A-Award 1,000,000 — 2008-06-04

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms